Trial Profile
A Double-Blind, Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Food allergy immunotherapy (Primary)
- Indications Milk hypersensitivity
- Focus Therapeutic Use
- Acronyms MILES
- Sponsors DBV Technologies
- 01 Feb 2021 Status changed from active, no longer recruiting to completed.
- 29 May 2018 Data from this trial were presented at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting, according to a DBV Technologies media release.
- 29 May 2018 Results presented in the DBV Technologies media release.